|
胃癌根治术后辅助治疗的临床分析
|
Abstract:
[1] | Kamangar, F., Dores, G.M. and Anderson, W.F. (2006) Patterns of Cancer Incidence, Mortality, and Prevalence across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World. Jour- nal of Clinical Oncology, 24, 2137-2150. http://dx.doi.org/10.1200/JCO.2005.05.2308 |
[2] | 陈万青, 张思维, 曾红梅, 等. 中国2010年恶性肿瘤发病与死亡[J]. 中国肿瘤, 2014, 23(1): 1-10. |
[3] | Siegel, R., Ma, J., Zou, Z., et al. (2014) Cancer Statistics, 2014. CA: A Cancer Journal for Clinicians, 64, 9-29.
http://dx.doi.org/10.3322/caac.21208 |
[4] | Hundahl, S.A., Phillips, J.L. and Menck, H.R. (2000) The National Cancer Data Base Report on Poor Survival of US Gastric Carcinoma Patients Treated with Gastrectomy: Fifth Edition American Joint Committee on Cancer stAging, Proximal Disease, and the “Different Disease” Hypothesis. Cancer, 88, 921-932.
http://dx.doi.org/10.1002/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.0.CO;2-S |
[5] | 詹友庆, 孙晓卫, 李威, 等. 影响根治术后胃癌预后的多因素分析[J]. 癌症, 2005, 24(5): 596-599. |
[6] | Nashimoto, A., Nakajima, T., Furukawa, H., et al. (2003) Randomized Trial of Adjuvant Chemotherapy with Mitomycin, Fluorouracil, and Cytosine Arabinoside Followed by Oral Fluorouracil in Serosa-Negative Gastric Cancer: Japan Clinical Oncology Group 9206-1. Journal of Clinical Oncology, 21, 2282-2287.
http://dx.doi.org/10.1200/JCO.2003.06.103 |
[7] | Bouché, O., Ychou, M., Burtin, P., et al. (2005) Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin Compared with Surgery Alone for Gastric Cancer: 7-Year Results of the FFCD Randomized Phase III Trial (8801). Annals of Oncology, 16, 1488-1497. http://dx.doi.org/10.1093/annonc/mdi270 |
[8] | De Vita, F., Giuliani, F., Orditura, M., et al. (2007) Adjuvant Chemotherapy with Epirubicin, Leucovorin, 5-Fluorou- racil and Etoposide Regimen in Resected Gastric Cancer Patients: A Randomized Phase III Trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study). Annals of Oncology, 18, 1354-1358.
http://dx.doi.org/10.1093/annonc/mdm128 |
[9] | Di Costanzo, F., Gasperoni, S., Manzione, L., et al. (2008) Adjuvant Chemotherapy in Completely Resected Gastric Cancer: A Randomized Phase III Trial Conducted by GOIRC. Journal of the National Cancer Institute, 100, 388-398.
http://dx.doi.org/10.1093/jnci/djn054 |
[10] | Kulig, J., Kolodziejczyk, P., Sierzega, M., et al. (2010) Adjuvant Chemotherapy with Etoposide, Adriamycin and Cisplatin Compared with Surgery Alone in the Treatment of Gastric Cancer: A Phase III Randomized, Multicenter, Clinical Trial. Oncology, 78, 54-61. http://dx.doi.org/10.1159/000292360 |
[11] | Sakuramoto, S., Sasako, M., Yamaguchi, T., et al. (2007) Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine. The New England Journal of Medicine, 357, 1810-1820. http://dx.doi.org/10.1056/NEJMoa072252 |
[12] | Bang, Y.J., Kim, Y.W., Yang, H.K., et al. (2012) Adjuvant Capecitabine and Oxaliplatin for Gastric Cancer after D2 Gastrectomy (CLASSIC): A Phase 3 Open-Label, Randomised Controlled Trial. Lancet, 379, 315-321.
http://dx.doi.org/10.1016/S0140-6736(11)61873-4 |
[13] | Webb, A., Cunningham, D., Scarffe, J.H., et al. (1997) Randomized Trial Comparing Epirubicin, Cisplatin, and Fluorouracil versus Fluorouracil, Doxorubicin, and Methotrexate in Advanced Esophagogastric Cancer. Journal of Clinical Oncology, 15, 261-267. http://dx.doi.org/10.1016/S0959-8049(97)86090-X |
[14] | Ross, P., Nicolson, M., Cunningham, D., et al. (2002) Prospective Randomized trial Comparing Mitomycin, Cisplatin, and Protracted Venous-Infusion Fluorouracil (PVI 5-FU) with Epirubicin, Cisplatin, and PVI 5-FU in Advanced Esophagogastric Cancer. Journal of Clinical Oncology, 20, 1996-2004. http://dx.doi.org/10.1200/JCO.2002.08.105 |
[15] | Van Cutsem, E., Moiseyenko, V.M., Tjulandin, S., et al. (2006) Phase III Study of Docetaxel and Cisplatin plus Fluorouracil Compared with Cisplatin and Fluorouracil as First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group. Journal of Clinical Oncology, 24, 4991-4997. http://dx.doi.org/10.1200/JCO.2006.06.8429 |
[16] | Roth, A.D., Fazio, N., Stupp, R., et al. (2007) Docetaxel, Cisplatin, and Fluorouracil; Docetaxel and Cisplatin; and Epirubicin, Cisplatin, and Fluorouracil as Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II trial of the Swiss Group for Clinical Cancer Research. Journal of Clinical Oncology, 25, 3217-3223.
http://dx.doi.org/10.1200/JCO.2006.08.0135 |
[17] | Macdonald, J.S., Smalley, S.R., Benedetti, J., et al. (2001) Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction. The New England Journal of Medicine, 345, 725-730. http://dx.doi.org/10.1056/NEJMoa010187 |
[18] | Lee, J., Lim do, H., Kim, S., et al. (2012) Phase III Trial Comparing Capecitabine plus Cisplatin versus Capecitabine plus Cisplatin with Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer with D2 Lymph Node Dissection: The ARTIST Trial. Journal of Clinical Oncology, 30, 268-273.
http://dx.doi.org/10.1200/JCO.2011.39.1953 |